COVID, vaccine
Digest more
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.
In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma company infringed on a patent describing protease inhibitors invented by its scientists. Enanta has now followed that up with another filing in Europe, making the same accusation.
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations.
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives with an added layer of uncertainty because it’s unclear when and which Americans can receive updated vaccines this fall.
Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of its subsidiaries, alleging that the pharma giant’s COVID-19 pill Paxlovid violated its European patent rights.
3d
Daily Express US on MSNPfizer's Covid-19 vaccine availability for children under 5 faces potential FDA roadblock
The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?
Kennedy accused the American Academy of Pediatrics of working for Big Pharma, even as he himself has profited from attacking vaccines.
A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated photograph.
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 variant, one of the most recently circulating novel coronavirus lineages. The authorization applies for individuals aged 6 months and older.